Raytherapeutics
2 known investors
Find your way into Raytherapeutics
Ray Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology. The company focuses on addressing unmet patient needs in ophthalmology through gene therapy innovation.
Founders & leadership
PB
Paul BresgeCo-founder & Chief Executive Officer
Investors · 2
Frequently asked questions
- What does Raytherapeutics do?
- Ray Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology. The company focuses on addressing unmet patient needs in ophthalmology through gene therapy innovation.
- Who founded Raytherapeutics?
- Raytherapeutics was founded by Paul Bresge.
- Who are Raytherapeutics's investors?
- Raytherapeutics's investors include Norwest Venture Partners, Novo Holdings.